Nvidia Invests $50M into AI Drug Discovery Firm Recursion

In this episode, we delve into Nvidia's substantial $50M investment in Recursion, a leading firm in AI drug discovery. We'll explore the strategic implications of this partnership, discuss how it might accelerate the application of AI in pharmaceutical research, and consider its potential to revolutionize drug discovery.

Get on the AI Box Waitlist: https://AIBox.ai/

Investor Contact Email: [email protected]

Sponsor the Podcast: [email protected]

Facebook Community: ⁠https://www.facebook.com/groups/739308654562189/⁠

Discord Community: https://aibox.ai/discord

Download Selfpause: https://selfpause.com/Podcast

⁠Inflection AI Report⁠

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.